Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3864)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2013 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tahiri M, Sodqi M, Lahdami FEZ, Marih L, Lamdini H, Hliwa W, Lahcen AO, Badre W, Haddad F, Chakib A, Bellabah A, Alaoui R, Filali KME. Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco. World J Hepatol 2013; 5(10): 584-588 [PMID: 24179618 DOI: 10.4254/wjh.v5.i10.584] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v5/i10/584.htm |
| Number | Citing Articles |
| 1 |
Raphael Mohr, Robert Schierwagen, Carolynne Schwarze-Zander, Christoph Boesecke, Jan-Christian Wasmuth, Jonel Trebicka, Jürgen Kurt Rockstroh. Liver Fibrosis in HIV Patients Receiving a Modern cART. Medicine 2015; 94(50): e2127 doi: 10.1097/MD.0000000000002127
|
| 2 |
Kathleen Ryan, Motswedi Anderson, Ivayla Gyurova, Lilliam Ambroggio, Sikhulile Moyo, Teresa Sebunya, Joseph Makhema, Richard Marlink, Max Essex, Rosemary Musonda, Simani Gaseitsiwe, Jason T Blackard. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infectious Diseases 2017; 4(4) doi: 10.1093/ofid/ofx195
|
| 3 |
Jing Ouyang, Silvere D. Zaongo, Xue Zhang, Miaomiao Qi, Aizhen Hu, Hao Wu, Yaokai Chen. Microbiota-Meditated Immunity Abnormalities Facilitate Hepatitis B Virus Co-Infection in People Living With HIV: A Review. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.755890
|
| 4 |
GV Matthews, J Neuhaus, S Bhagani, SH Mehta, E Vlahakis, M Doroana, S Naggie, A Arenas‐Pinto, L Peters, JK Rockstroh. Baseline prevalence and predictors of liver fibrosis among HIV‐positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015; 16(S1): 129 doi: 10.1111/hiv.12241
|
| 5 |
Kombo F N’Guessan, Motswedi Anderson, Bonolo Phinius, Sikhulile Moyo, Alyyah Malick, Tshepiso Mbangiwa, Wonderful T Choga, Joseph Makhema, Richard Marlink, Max Essex, Rosemary Musonda, Simani Gaseitsiwe, Jason T Blackard. The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana. Open Forum Infectious Diseases 2017; 4(4) doi: 10.1093/ofid/ofx222
|
| 6 |
Katherine W. Kooij, Ferdinand W.N.M. Wit, Rosan A. van Zoest, Judith Schouten, Neeltje A. Kootstra, Michèle van Vugt, Maria Prins, Peter Reiss, Marc van der Valk. Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy. AIDS 2016; 30(11): 1771 doi: 10.1097/QAD.0000000000001119
|
| 7 |
Astrid M. Newsum, Katherine W. Kooij, Anders Boyd, Colette Smit, Ferdinand W.N.M. Wit, Jan T.M. van der Meer, Maria Prins, Peter Reiss, Marc van der Valk. Progression of liver fibrosis following acute hepatitis C virus infection in HIV-positive MSM. AIDS 2019; 33(5): 833 doi: 10.1097/QAD.0000000000002138
|
| 8 |
Kazuya Kariyama, Kazuhiro Nouso, Hidenori Toyoda, Toshifumi Tada, Atsushi Hiraoka, Kunihiko Tsuji, Ei Itobayashi, Toru Ishikawa, Akiko Wakuta, Ayano Oonishi, Takashi Kumada, Masatoshi Kudo, on behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group, HCC fourtyeight Group. Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma. Cancers 2019; 11(2): 203 doi: 10.3390/cancers11020203
|
| 9 |
Takahiko Akiyama, Yuji Miyamoto, Katsunori Imai, Yoichi Yamashita, Daichi Nomoto, Nobuya Daitoku, Yuki Sakamoto, Yuki Kiyozumi, Ryuma Tokunaga, Kojiro Eto, Kazuto Harada, Yukiharu Hiyoshi, Masaaki Iwatsuki, Yohei Nagai, Shiro Iwagami, Yoshifumi Baba, Naoya Yoshida, Hideo Baba. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases. Annals of Surgical Oncology 2020; 27(9): 3534 doi: 10.1245/s10434-020-08828-5
|
| 10 |
Cristina Mussini, Patrizia Lorenzini, Massimo Puoti, Miriam Lichtner, Giuseppe Lapadula, Simona Di Giambenedetto, Andrea Antinori, Giordano Madeddu, Alessandro Cozzi-Lepri, Antonella d’Arminio Monforte, Andrea De Luca, Wenyu Lin. Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus. PLOS ONE 2015; 10(12): e0140877 doi: 10.1371/journal.pone.0140877
|
| 11 |
Theodoros Androutsakos, Maria Schina, Abraham Pouliakis, Athanasios Kontos, Nikolaos Sipsas, Gregorios Hatzis. Liver Fibrosis Assessment in a Cohort of Greek HIV Mono-Infected Patients by Non-Invasive Biomarkers. Current HIV Research 2019; 17(3): 173 doi: 10.2174/1570162X17666190809153245
|
| 12 |
Lumin Zhang, Meena B. Bansal. Role of Kupffer Cells in Driving Hepatic Inflammation and Fibrosis in HIV Infection. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01086
|
| 13 |
Brenda Nherera, Kudakwashe Mhandire, Tinashe K. Nyazika, Alfred Makura, Cuthbert Musarurwa, Prichard T. Mapondera, Babill Stray-Pedersen, Hilda T. Matarira. Comparison of non-invasive methods of assessing liver fibrosis in combination ART-experienced Zimbabweans. Southern African Journal of HIV Medicine 2019; 20(1) doi: 10.4102/sajhivmed.v20i1.844
|
| 14 |
Karima Abounouh, Imane Aitraise, Anas Benabou, Ikhlass Boussakri, Mohamed Amine Doumir, Chaimaa El Boussairi, Soukaina El Idrissi, Chaimae El Mahdaoui, Dalal El Qouar, Afaf Ennahal, Sofia Fathi, Maria Hafidi, Lamyae Lachker, Chorouk Ratib, Ikram-Allah Tanouti, Abderrahmane Maaroufi, Soumaya Benjelloun, Fadila Guessous, Pascal Pineau, Sayeh Ezzikouri. Virus-associated human cancers in Moroccan population: From epidemiology to prospective research. Infection, Genetics and Evolution 2019; 75: 103990 doi: 10.1016/j.meegid.2019.103990
|
| 15 |
Jürgen K. Rockstroh, Raphael Mohr, Georg Behrens, Ulrich Spengler. Liver fibrosis in HIV. Current Opinion in HIV and AIDS 2014; 9(4): 365 doi: 10.1097/COH.0000000000000064
|
| 16 |
G. Lui, V. W.‐S. Wong, G. L.‐H. Wong, W. C.‐W. Chu, C.‐K. Wong, I. M. H. Yung, R. Y. K. Wong, S.‐L. Yeung, D. K.‐W. Yeung, C. S. K. Cheung, H.‐Y. Chan, H. L.‐Y. Chan, N. Lee. Liver fibrosis and fatty liver in Asian HIV‐infected patients. Alimentary Pharmacology & Therapeutics 2016; 44(4): 411 doi: 10.1111/apt.13702
|
| 17 |
Rongrong Yang, Xien Gui, Hengning Ke, Yong Xiong, Shicheng Gao. Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection. AIDS Research and Therapy 2021; 18(1) doi: 10.1186/s12981-021-00419-y
|
| 18 |
Deepti Gupta, Manjusha Rani, Nabab Khan, Shahid Jameel, Neerja Kaushik-Basu. HIV-1 Infected Peripheral Blood Mononuclear Cells Modulate the Fibrogenic Activity of Hepatic Stellate Cells through Secreted TGF-β and JNK Signaling. PLoS ONE 2014; 9(3): e91569 doi: 10.1371/journal.pone.0091569
|